Author:
Hainsworth J.D.,Urba W.J.,Hon J.K.,Thompson K.A.,Stagg M.P.,Hopkins L.G.,Thomas M.,Greco F.A.
Reference13 articles.
1. Murphy WK, Fossella FV, Winn RJ, et al. Phase II study of Taxol in patients with untreated advanced non-small cell lung cancer. J Natl Cancer Inst 1993, 85, 384–388.
2. Chang AY, Kim K, Glick J, et al. Phase II study of Taxol, merbarone, and piroxantrone in stage IV non-small cell lung cancer: the Eastern Cooperative Oncology Group results. J Natl Cancer Inst 1993, 85, 388–394.
3. Paclitaxel by 1-hour infusion: an active drug in metastatic non-small cell lung cancer;Hainsworth;J Clin Oncol,1995
4. Langer CJ, Leighton JC, Comis RL, et al. Paclitaxel and carboplatin in combination in the treatment of advanced non-small cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol 1995, 13, 1860–1870.
5. Vafai D, Israel V, Zaretsky S, Natale RB. Phase I/II trial of combination carboplatin and Taxol in non-small cell lung cancer. Proc Am Soc Clin Oncol 1995, 14, 352 (Abstr.).
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献